Generative AI, peptide design and digital twins are speeding discovery. Here is where the shortcut stops.
Sep 16, 2026
•
5 min read
How generative design, digital twins and human trials fit together, and where the shortcut stops.
Sep 13, 2026
One trial, three clocks, different answers. What to ask before paying for a younger number.
Sep 9, 2026
What the number means, why it can move, and when it should change a decision.
Sep 6, 2026
Wall squats beat running, salt beat a drug trial, and a Class 3 verdict on your wrist.
Sep 2, 2026
9 min read
Five compounds, five different ways the evidence gives way — and three rules you can take to any peptide claim you meet next.
Sep 1, 2026
8 min read
The FDA's own scientists said no 🧬. Six of seven cleared a panel its own scientists opposed.
Aug 26, 2026
From tirzepatide to epitalon — one A-to-F scale, applied to the compounds an FDA panel has just voted to bring within reach.
10 min read
A 66-item side-effect list that shrank to four, and a supplement the EU just voted to ban.
Aug 19, 2026
Statins, ezetimibe, bempedoic acid and a fermented rice — four routes to one receptor, and why your arteries can't tell which one you took
Aug 16, 2026
6 min read
The £0 number that beats the £299 panel. One free calculation you can do tonight, one test worth £30 if you're in the right group, and one you only ever need once.
Aug 12, 2026
One protein per particle, millions of particles, and the reason lifetime exposure beats any number you can measure on a Tuesday morning
13% - That's how much lower the risk of dying ran for each single MET of extra fitness, across 33 studies and more than 100,000 people. A MET is your whole resting metabolism.
Aug 5, 2026
Four hundred and eighty-one people, one supervised twenty-week programme, and a spread in results that launched thirty years of argument about whether "non-responder" is a real thing.
Aug 3, 2026
7 min read
Lifting graded A, protein graded B, and the £37 powder most people don't need.
Jul 29, 2026